Biomimetic Nanoparticles for Disease Treatment and Diagnosis

Dear Colleagues,

Biomimetic nanoparticles are a new group of nanoparticles that combine the functionality of biological materials with the flexibility of synthetic materials to overcome biological barriers and achieve improved targeting in complex biological systems. These biomimetic platforms include cell membrane-coated nanoparticles, DNA nanodevices, and other hybrid nanoparticles. They have demonstrated significant potential to increase therapeutic efficacy in disease treatment and diagnosis by combining natural biological functionality with the ability of synthetic structures to transport imaging reporters and therapeutic cargo. In addition, the incorporation of cell-based biological materials offers benefits such as immune escape, prolonged blood circulation time, and specific/precise targeting.

This Special Issue aims to provide a platform for prominent scientists from all over the world to showcase their work and discuss current progress in the use of biomimetic nanoparticles for biomedical applications. 

Dr. Tianqing (Michelle) Liu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.